Comparison between Aster DM Healthcare IPO and Galaxy Surfactants IPO.
Aster DM Healthcare IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Galaxy Surfactants IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Aster DM Healthcare IPO is up to ₹980.14 Cr whereas the issue size of the Galaxy Surfactants IPO is up to ₹937.09 Cr. The final issue price of Aster DM Healthcare IPO is ₹190.00 per share and of Galaxy Surfactants IPO is ₹1,480.00 per share.
| Aster DM Healthcare IPO | Galaxy Surfactants IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹180.00 per share | ₹1,470.00 per share |
| Issue Price (Upper) | ₹190.00 per share | ₹1,480.00 per share |
| Issue Price (Final) | ₹190.00 per share | ₹1,480.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 78 shares | 10 shares |
| Fresh Issue Size | 3,81,57,894 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹725.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 1,34,28,251 shares | 63,31,674 shares |
| OFS Issue Size (Amount) | up to ₹255.14 Cr | up to ₹937.09 Cr |
| Issue Size Total | 5,15,86,145 shares | 63,31,674 shares |
| Issue Size Total (Amount) | up to ₹980.14 Cr | up to ₹937.09 Cr |
Aster DM Healthcare IPO opens on Feb 12, 2018, while Galaxy Surfactants IPO opens on Jan 29, 2018. The closing date of Aster DM Healthcare IPO and Galaxy Surfactants IPO is Feb 15, 2018, and Jan 31, 2018, respectively.
| Aster DM Healthcare IPO | Galaxy Surfactants IPO | |
|---|---|---|
| Anchor Bid Date | Feb 09, 2018 | Jan 25, 2018 |
| Issue Open | Feb 12, 2018 | Jan 29, 2018 |
| Issue Close | Feb 15, 2018 | Jan 31, 2018 |
| Basis Of Allotment (Tentative) | Feb 22, 2018 | Feb 05, 2018 |
| Initiation of Refunds (Tentative) | Feb 22, 2018 | Feb 06, 2018 |
| Credit of Share (Tentative) | Feb 23, 2018 | Feb 07, 2018 |
| Listing date (Tentative) | Feb 26, 2018 | Feb 08, 2018 |
| Anchor Lockin End date 1 | Mar 24, 2018 | Mar 07, 2018 |
| Anchor Lockin End date 2 | May 23, 2018 | May 06, 2018 |
Aster DM Healthcare IPO P/E ratio is , as compared to Galaxy Surfactants IPO P/E ratio of .
| Aster DM Healthcare IPO | Galaxy Surfactants IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹9599.32 Cr. | ₹5247.30 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Aster DM Healthcare IPO Retail Individual Investors (RII) are offered 1,80,55,151 shares while in Galaxy Surfactants IPO retail investors are offered 1,80,55,151 shares. Qualified Institutional Buyers (QIB) are offered 1,03,17,229 shares in Aster DM Healthcare IPO and 12,66,336 shares in Galaxy Surfactants IPO.
| Aster DM Healthcare IPO | Galaxy Surfactants IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,54,75,843 shares | 18,99,500 shares |
| Market Maker Reservation | ||
| QIB | 1,03,17,229 shares | 12,66,336 shares |
| NII | 77,37,922 shares | 9,49,752 shares |
| RII | 1,80,55,151 shares | 22,16,086 shares |
| Employee | ||
| Others | ||
| Total | 5,15,86,145 shares | 63,31,674 shares |
Aster DM Healthcare IPO subscribed 1.31x in total, whereas Galaxy Surfactants IPO subscribed 19.96x.
| Aster DM Healthcare IPO | Galaxy Surfactants IPO | |
|---|---|---|
| QIB (times) | 2.10x | 54.27x |
| NII (times) | 0.55x | 6.96x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.18x | 5.92x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.31x | 19.96x |
